Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 10/20 | 0.52 |
| ▸ | CA2 | P00918 | 8/20 | 0.52 |
| ▸ | CA1 | P00915 | 7/20 | 0.52 |
| ▸ | CA9 | Q16790 | 7/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.52 |
| ▸ | CA4 | P22748 | 5/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8764363 | 0.94 | CA2 (0.48) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8765747 | 0.89 | PTGS2 (0.60) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8764457 | 0.89 | PTGS2 (0.48) | PTGS2PTGS1 | |
| SCHEMBL8765925 | 0.89 | PTGS2 (0.51) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8765145 | 0.88 | PTGS2 (0.60) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8765306 | 0.88 | PTGS2 (0.47) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8764362 | 0.88 | PTGS2 (0.48) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8765285 | 0.88 | PTGS2 (0.60) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8766233 | 0.88 | PTGS2 (0.52) | PTGS2CA2CA1PTGS1 | |
| SCHEMBL27459433 | 0.88 | PTGS2 (0.58) | PTGS2CA2CA1CA9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731794-B1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | SEARLE & CO (US) | 1997-08-06 | — | — | EP | disclosed |
| US-5639777-A | 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders | G.D. SEARLE & CO. (US) | 1997-06-17 | — | — | US | disclosed |
| EP-0731794-A1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | SEARLE & CO (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015317-A1 | 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | disclosed |